Guidance for industry on Pediatric Drug Development Under the Pediatric Research Equity Act and Qualifying for Pediatric Exclusivity Under the Best Pharmaceuticals for Children Act

3 organizations filed 4 public comments on Guidance for industry on Pediatric Drug Development Under the Pediatric Research Equity Act and Qualifying for Pediatric Exclusivity Under the Best Pharmaceuticals for Children Act, at the Food and Drug Administration. The comment window closed 1107d ago.

Abstract

Docket Status: OPEN

Commenters (3)

• American Academy of Pediatrics (AAP)

  2 filings · confidence 97%
• American Society of Hematologytrade assoc.

  1 filing · confidence 85%
• Eli Lilly and Companyunverified attribution

  1 filing · confidence 70%